[The use of antibiotic-resistant Bifidobacterium biphidum and Lactobacillus acidophilus in the course of antibiotic therapy].
D000191:Actinomycetaceae / Q000187:drug effects; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001424:Bacterial Infections / Q000628:therapy*; D001991:Bronchitis / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000628:therapy; D004660:Encephalitis / Q000628:therapy; D005260:Female; D006525:Hepatitis, Viral, Human / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007779:Lactobacillus acidophilus / Q000187:drug effects; D008297:Male; D011014:Pneumonia / Q000628:therapy; D012141:Respiratory Tract Infections / Q000628:therapy*; D014069:Tonsillitis / Q000628:therapy; D014397:Tuberculosis, Pulmonary / Q000628:therapy; D014552:Urinary Tract Infections / Q000628:therapy*
D000900:Anti-Bacterial Agents
Ricerche sull'impiego in corso di trattamento antibiotico di Bifidobacterium biphidum e Lactobacillus acidophilus antibiotico-resistenti.